doxepin has been researched along with Obstructive Lung Diseases in 1 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Light, RW | 1 |
| Merrill, EJ | 1 |
| Despars, J | 1 |
| Gordon, GH | 1 |
| Mutalipassi, LR | 1 |
1 trial available for doxepin and Obstructive Lung Diseases
| Article | Year |
|---|---|
Doxepin treatment of depressed patients with chronic obstructive pulmonary disease.
Topics: Aged; Anxiety; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Doxepin; Emotions | 1986 |